[Use of a combination of enoxaparin or unfractionated heparin and abciximab during percutaneous coronary interventions: a randomized pilot study].
about
Administration of low molecular weight and unfractionated heparin during percutaneous coronary interventionEfficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysisSafety of intra-aortic balloon pump using glycoprotein IIb/IIIa antagonists.
P2860
[Use of a combination of enoxaparin or unfractionated heparin and abciximab during percutaneous coronary interventions: a randomized pilot study].
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
[Use of a combination of enoxa ...... ns: a randomized pilot study].
@ast
[Use of a combination of enoxa ...... ns: a randomized pilot study].
@en
type
label
[Use of a combination of enoxa ...... ns: a randomized pilot study].
@ast
[Use of a combination of enoxa ...... ns: a randomized pilot study].
@en
prefLabel
[Use of a combination of enoxa ...... ns: a randomized pilot study].
@ast
[Use of a combination of enoxa ...... ns: a randomized pilot study].
@en
P2093
P1476
[Use of a combination of enoxa ...... ns: a randomized pilot study].
@en
P2093
Angel Sánchez-Recalde
Guillermo Galeote
José A Sobrino
Luis Calvo
Monser Hussein
Nicolás Sobrino
P304
P356
10.1016/S0300-8932(02)76798-5
P407
P577
2002-12-01T00:00:00Z